1. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing. Issue 5 (6th August 2014) Authors: Caudle, K E; Rettie, A E; Whirl‐Carrillo, M; Smith, L H; Mintzer, S; Lee, M T M; Klein, T E; Callaghan, J T Journal: Clinical pharmacology & therapeutics Issue: Volume 96:Issue 5(2014) Page Start: 542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update. Issue 4 (23rd January 2014) Authors: Crews, K R; Gaedigk, A; Dunnenberger, H M; Leeder, J S; Klein, T E; Caudle, K E; Haidar, C E; Shen, D D; Callaghan, J T; Sadhasivam, S; Prows, C A; Kharasch, E D; Skaar, T C Journal: Clinical pharmacology & therapeutics Issue: Volume 95:Issue 4(2014) Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen‐B Genotype and Allopurinol Dosing. Issue 2 (17th October 2012) Authors: Hershfield, M S; Callaghan, J T; Tassaneeyakul, W; Mushiroda, T; Thorn, C F; Klein, T E; Lee, M T M Journal: Clinical pharmacology & therapeutics Issue: Volume 93:Issue 2(2013) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗